Chet Metcalf
Vice President - Research & Development Chemistry Regeneron Pharmaceuticals
Seminars
Monday 12th October 2026
Pushing the Boundary of Novel Bioconjugate Mechanisms & Design
Monday 12th October 2026
Spotlighting Discovery of Novel Linker Payloads to Set the Path for the Next Wave of Differentiated Antibody Conjugates
12:30 pm
- Breaking down discovery and lessons learned from REGN5093 (METxMET)-M114 biparatopic ADC
- Exploring the Regeneron ProDXd platform for discovery and development of differentiated ADCs
- Assessing novelty and discovery ot targeting GPCRs with Antibody Tethered Ligand (ATL) conjugates
Monday 12th October 2026
Summary Panel Discussion: Discussing the Future of ADC Chemistry & Design to Herald a New Era of Bioconjugate Innovation
3:00 pm
At the end of the seminar day, don’t miss this summary panel discussion to discuss, debate and challenge your speakers and ADC peers on the cutting-edge of ADC design, exploring the most promising areas of ADC innovation, benefits against traditional therapies, and hurdles to advance novel conjugates into and through the clinic.
